Sovaldi and Multiple fractures - a phase IV clinical study of FDA data
Summary:
We study 38,672 people who take Sovaldi (sofosbuvir) or have Multiple fractures. No report of Multiple fractures is found in people who take Sovaldi.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Sovaldi?
Sovaldi has active ingredients of sofosbuvir. eHealthMe is studying from 12,697 Sovaldi users. Check the latest studies of Sovaldi.
What is Multiple Fractures?
Multiple fractures is found to be associated with 730 drugs and 725 conditions by eHealthMe. Check the latest studies of Multiple fractures.
No report is found.
Do you take Sovaldi and have Multiple fractures?
- Check whether Multiple fractures is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sovaldi:
- Sovaldi (12,697 reports)
Multiple fractures treatments and more:
- Multiple fractures (25,975 reports)
How severe was Multiple fractures and when was it recovered:
Expand to all the drugs that have ingredients of sofosbuvir:
Browse all side effects of Sovaldi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Multiple fractures:
Browse all the conditions that are associated with Multiple fractures:
How the study uses the data?
The study uses data from the FDA. It is based on sofosbuvir (the active ingredients of Sovaldi) and Sovaldi (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Proscar cause Musculoskeletal Discomfort? - 3 seconds ago
- Metoprolol Succinate and Throat Tightness for Men aged 60+ - 7 seconds ago
- Miralax and Ms Contin drug interactions for men aged 50-59 - 18 seconds ago
- Nicotine and Caffeine drug interactions for girls aged 10-19 - 19 seconds ago
- Could Prograf cause Electroencephalogram Abnormal? - 23 seconds ago
- Enlarged Prostate and Overdose - 23 seconds ago
- Secretion Discharge and Wheezing - 23 seconds ago
- Valproate Sodium and Zyprexa drug interactions for men aged 40-49 - 25 seconds ago
- Could Tamoxifen Citrate cause Hypotension? - 56 seconds ago
- Could Sulfasalazine cause Renal Neoplasm? - a minute ago